PTK787/ZK222584

DRUG4 trials

Sponsors

University of Helsinki, Dana-Farber Cancer Institute, Pancreatic Cancer Research Team, Washington University School of Medicine

Conditions

Breast NeoplasmsMultiple MyelomaNeoplasmSarcoma

Phase 2

PTK787/ZK222584 in the Treatment of Metastatic Gastrointestinal Stromal Tumors Resistant to Imatinib

CompletedNCT00117299

University of HelsinkiSarcoma

Start: 2004-09-30End: 2009-01-31Updated: 2010-05-27

Protein Tyrosine Kinases (PTK) in Multiple Myeloma

CompletedNCT00165347

Dana-Farber Cancer InstituteMultiple Myeloma

Start: 2003-12-31End: 2006-10-31Target: 10Updated: 2007-12-21

PTK787 in Patients With Advanced Metastatic Pancreatic Adenocarcinoma

CompletedNCT00226005

Pancreatic Cancer Research TeamNeoplasm

Start: 2005-12-31End: 2010-02-28Updated: 2012-05-09

PTK and Letrozole in Post-menopausal Women With Advanced Breast Cancer

TerminatedNCT00263198

Washington University School of MedicineBreast Neoplasms

Start: 2006-03-31End: 2006-11-30Updated: 2013-05-07